ES8503503A1 - Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso - Google Patents

Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso

Info

Publication number
ES8503503A1
ES8503503A1 ES532018A ES532018A ES8503503A1 ES 8503503 A1 ES8503503 A1 ES 8503503A1 ES 532018 A ES532018 A ES 532018A ES 532018 A ES532018 A ES 532018A ES 8503503 A1 ES8503503 A1 ES 8503503A1
Authority
ES
Spain
Prior art keywords
delivery system
drug delivery
osmotic drug
osmotic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532018A
Other languages
English (en)
Other versions
ES532018A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8503503(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of ES532018A0 publication Critical patent/ES532018A0/es
Publication of ES8503503A1 publication Critical patent/ES8503503A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

DISPOSITIVO PARA LIBERAR A UNA VELOCIDAD CONTROLADA UN AGENTE BENEFICIOSO A UN MEDIO DE USO.COMPRENDE UN CUERPO (11) Y UNA PARED (12) CONSTITUIDA POR UNA COMPOSICION PERMEABLE AL PASO DE UN FLUIDO EXTERNO PRESENTE EN EL MEDIO DE USO Y FORMA Y RODEA; UN COMPARTIMIENTO CON UNA PRIMERA COMPOSICION (14) QUE CONTIENE UN AGENTE BENEFICIOSO (15), UN OSMOAGENTE (16) Y UN OSMOPOLIMERO (17) Y CON UNA SEGUNDA COMPOSICION QUE CONTIENE UN OSMOAGENTE (18) Y UN OSMOPOLIMERO (19); Y UN PASO (13) QUE COMUNICA LA PRIMERA COMPOSICION CON EL EXTERIOR DEL DISPOSITIVO (10).
ES532018A 1983-05-11 1984-04-27 Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso Expired ES8503503A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (2)

Publication Number Publication Date
ES532018A0 ES532018A0 (es) 1985-03-01
ES8503503A1 true ES8503503A1 (es) 1985-03-01

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532018A Expired ES8503503A1 (es) 1983-05-11 1984-04-27 Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso

Country Status (20)

Country Link
JP (1) JPS6041609A (es)
AT (1) AT397180B (es)
AU (1) AU566110B2 (es)
BE (1) BE898819A (es)
CA (1) CA1222950A (es)
CH (1) CH669329A5 (es)
DE (1) DE3417113A1 (es)
DK (1) DK163910C (es)
ES (1) ES8503503A1 (es)
FR (1) FR2545721B1 (es)
GB (1) GB2140687B (es)
IE (1) IE56515B1 (es)
IL (1) IL71727A (es)
IT (1) IT1178911B (es)
MX (1) MX163518B (es)
NL (1) NL192250C (es)
NO (1) NO170834C (es)
NZ (1) NZ206600A (es)
SE (1) SE455918B (es)
ZA (1) ZA842422B (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
ES2037179T3 (es) * 1987-11-25 1993-06-16 American Cyanamid Company Sistema de liberacion sostenida (controlada) para bloqueadores de canales de calcio de dihidropiridina.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
DE69107461T2 (de) * 1990-08-07 1995-06-22 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
ES2053339T3 (es) * 1990-09-28 1994-07-16 Pfizer Dispositivo dispensador conteniendo un medio hidrofobo.
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
DE69426997T2 (de) * 1993-02-23 2001-11-15 Heikki Sirkkola Die Verwendung eines Calciumpräparates in einem Medikament zur Behandlung von an Hypocalcämie leidenden Milchkühen
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR101045144B1 (ko) * 2000-10-30 2011-06-30 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US8163306B2 (en) * 2003-09-19 2012-04-24 Sun Pharma Advanced Research Company Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
RU2578602C2 (ru) 2005-10-04 2016-03-27 Байер Интеллектуэль Проперти Гмбх Способ получения 5-хлор-n-(5s)-2-оксо-3-[4-(3-оксо-морфолинил)-фенил]-1,3-оксазолидин-5-ил}-метил)-2-тиофенкарбоксамида в модификации ii (варианты)
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US8956654B2 (en) * 2009-06-02 2015-02-17 Dow Global Technologies Llc Sustained release dosage form
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
JP6231553B2 (ja) 2012-05-07 2017-11-15 バイエル ファーマ アクチエンゲゼルシャフト ニフェジピンおよびカンデサルタン・シレキセチルを含む医薬投与形を製造する方法
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
CN112469398A (zh) 2018-07-24 2021-03-09 拜耳公司 可口服给药并具有缓释作用的药物剂型
JOP20210019A1 (ar) 2018-07-24 2021-01-24 Bayer Ag شكل جرعة صيدلانية تعطى عن طريق الفم ذات اطلاق مُعدّل
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE376851B (es) * 1971-01-13 1975-06-16 Alza Corp
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
DE3417113A1 (de) 1984-11-15
NO170834B (no) 1992-09-07
ES532018A0 (es) 1985-03-01
GB2140687A (en) 1984-12-05
NL192250C (nl) 1997-04-03
DK163910C (da) 1992-09-14
NZ206600A (en) 1987-01-23
NL192250B (nl) 1996-12-02
GB8334189D0 (en) 1984-02-01
SE8402512L (sv) 1984-11-12
AU566110B2 (en) 1987-10-08
GB2140687B (en) 1987-03-18
IT8467283A1 (it) 1985-09-23
DE3417113C2 (es) 1989-02-02
AT397180B (de) 1994-02-25
BE898819A (fr) 1984-05-30
IT1178911B (it) 1987-09-16
AU2251183A (en) 1984-11-15
ATA88084A (de) 1993-07-15
SE8402512D0 (sv) 1984-05-09
JPH0575725B2 (es) 1993-10-21
SE455918B (sv) 1988-08-22
IL71727A (en) 1989-01-31
IE840010L (en) 1984-11-11
DK163910B (da) 1992-04-21
ZA842422B (en) 1984-11-28
NL8401470A (nl) 1984-12-03
NO840248L (no) 1984-11-12
DK99784D0 (da) 1984-02-24
NO170834C (no) 1992-12-16
CA1222950A (en) 1987-06-16
IL71727A0 (en) 1984-09-30
DK99784A (da) 1984-11-12
IT8467283A0 (it) 1984-03-23
MX163518B (es) 1992-05-25
IE56515B1 (en) 1991-08-28
CH669329A5 (es) 1989-03-15
FR2545721A1 (fr) 1984-11-16
JPS6041609A (ja) 1985-03-05
FR2545721B1 (fr) 1987-11-06

Similar Documents

Publication Publication Date Title
ES8503503A1 (es) Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso
ES8705240A1 (es) Dispositivo osmotico para la administracion controlada de unagente benefico a un ambiente de utilizacion
SE8401185L (sv) Osmotiskt system med omedelbar lekemedelstillgenglighet
ES2008580A6 (es) Forma de dosificacion para la liberacion rapida y lenta de agente beneficioso.
ZA907180B (en) Implantable delivery dispenser
EP0082182A4 (en) COMPOSITION CONTAINING EMOSTATIC AGENT FACTOR VII A AND METHOD FOR THE PRODUCTION THEREOF.
EP0203186A4 (en) MEDICATION DELIVERY APPARATUS FOR PREVENTING SYSTEMIC TOXICITY AND LOCAL TOXICITY.
ES282407U (es) Una capsula osmotica para la liberacion a velocidad controlada de una formulacion de un agente util
ES8802113A1 (es) Metodo de fabricacion de un nuevo sistema distribuidor para la descarga a velocidad controlada de farmacos beneficiosos
GR3024468T3 (en) Inhalation powder containing antistatic agent.
IL92225A0 (en) Delivery systems containing aminopolysaccharide derivatives for the delivery of pharmaceutically active materials
AU8729682A (en) Low delivery cigarette
CA2052076A1 (en) Oxygen enrichment method and system
DE3369468D1 (en) Osmotic drug delivery system
USD278599S (en) Bottle
ES8601698A1 (es) Procedimiento para producir preparados farmaceuticos a base de heparina y agentes tensioactivos.
EP0287210A3 (en) Therapeutic compositions
AU8539082A (en) Azabicyclo(3,2,1)octyl and (3,3,1) nonyl benzamides
GB8422485D0 (en) Drug delivery system
ES8800043A1 (es) Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
USD278411S (en) Bottle
USD293156S (en) Bathing suit or the like
AU5848386A (en) Agent delivery systems
USD264892S (en) Tie or similar article
AU550096B2 (en) Dibenzo-1,4-dioxepins and their thia analogues